VIROCYT
ViroCyt focuses on the commercialization of novel technologies that enable the rapid quantification of viruses. Our goal is to provide the tools that deliver meaningful improvements to mission-critical processes, such as vaccine manufacturing, protein expression, antiviral development, and other settings where viruses play a significant role. It was founded in 2012 and is based in Broomfield, Colorado.
VIROCYT
Industry:
Biotechnology CRM Health Care Health Diagnostics Information Technology Manufacturing Medical Device
Founded:
2012-01-01
Address:
Broomfield, Colorado, United States
Country:
United States
Website Url:
http://www.virocyt.com
Total Employee:
11+
Status:
Closed
Contact:
(720) 599-3700
Email Addresses:
[email protected]
Total Funding:
8.17 M USD
Technology used in webpage:
Domain Not Resolving SPF ReCAPTCHA Microsoft Exchange Online Microsoft Azure DNS Gravity Forms Salesforce Salesforce Web To Lead EuroDNS DNS
Current Employees Featured
Official Site Inspections
http://www.virocyt.com
- Host name: 217.19.13.9
- IP address: 217.19.13.9
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "ViroCyt"
ViroCyt - Crunchbase Company Profile & Funding
ViroCyt focuses on the commercialization of novel technologies that enable the rapid quantification of viruses. Our goal is to provide the tools that deliver …See details»
ViroCyt Company Profile 2024: Valuation, Investors, Acquisition
Developer of rapid quantification technology for viruses. The company provides the tools that deliver biotechnology processes such as vaccine manufacturing, protein expression and …See details»
ViroCyt - VentureRadar
ViroStat provides infectious disease antibody tools to researchers and manufacturers. These include the areas of virology, bacteriology and parasitology. Applications for these include …See details»
ViroCyt, Inc. - LinkedIn
ViroCyt, Inc. | 631 followers on LinkedIn. Virocyt was created in 2012 to focus on the commercialization of novel technologies that enable rapid quantification of viruses.See details»
Sartorius Acquires US Start-Up ViroCyt - bioprocessintl.com
Jul 15, 2016 · Sartorius, a leading international pharmaceutical and laboratory tools provider, today announced the acquisition of ViroCyt Incorporated, an innovator in the field of rapid virus …See details»
ViroCyt - Products, Competitors, Financials, Employees, …
Virocyt is focused on the commercialization of technologies that enable rapid quantification of viruses. The company's goal is to provide the tools that deliver meaningful improvements to …See details»
ViroCyt | Scientist.com
ViroCyt is the leader in the field of rapid virus quantification. Our goal is to provide the tools that deliver meaningful improvements to mission critical processes, such as vaccine …See details»
Sartorius acquires U.S. start-up ViroCyt
Goettingen, July 15, 2016 – Sartorius, a leading international pharmaceutical and laboratory tools provider, today announced the acquisition of ViroCyt Incorporated, an innovator in the field of …See details»
Sartorius acquires ViroCyt - 2016-07-15 - Crunchbase
Jul 15, 2016 · ViroCyt ViroCyt is focused on the commercialization of novel technologies that enable rapid quantification of viruses. Acquiring Organization: Sartorius Sartorius helps its …See details»
ViroCyt - Tech Stack, Apps, Patents & Trademarks - Crunchbase
ViroCyt uses 16 technology products and services including HTML5, DigiCert, and Wordpress, according to G2 Stack.See details»
Sartorius buys virus counting tech firm ViroCyt for $16m
Jul 15, 2016 · ViroCyt’s core technology in an automated virus particle counting system the firm claims can tell biopharmaceutical developers how many intact virus particles are present in culture samples in minutes. The firm has also …See details»
Sartorius Acquires ViroCyt - American Pharmaceutical Review
Jul 15, 2016 · Sartorius has announced the acquisition of ViroCyt Incorporated, an innovator in the field of rapid virus quantification. Based in Broomfield, Colorado, USA, the start-up is …See details»
Sartorius Acquires ViroCyt for $16M - genengnews.com
Jul 15, 2016 · Sartorius said today it has acquired ViroCyt for $16 million in a deal that expands the buyer’s lab products and services offerings by adding the developer of rapid virus …See details»
ViroCyt acquired by Sartorius - manufacturingchemist.com
Jul 15, 2016 · ViroCyt, a leader in rapid virus quantification, has been acquired by Sartorius, a leading international pharmaceutical and laboratory tools provider. The approximate valuation …See details»
Colorado-based ViroCyt raises $3.5M to market its Virus Counter
Jan 21, 2015 · With ViroCyt’s Virus Counter, a lab-based technology that allows scientists to determine the amount of virus particles in a sample, researchers can get results in a matter of …See details»
Rapid and Direct Quantification of Viral Particles for Gene Therapy
Feb 12, 2016 · ViroCyt’s approach to titrating viral particles can produce real-time results, allowing the benefits of in-process monitoring—optimized growth conditions, maximized yields, and more.See details»
Evaluation of ViroCyt ® Virus Counter for Rapid Filovirus …
Feb 20, 2015 · The ViroCyt ® Virus Counter (VC) 2100 (ViroCyt, Boulder, CO, USA) instrument is a reengineered non-sorting analytical flow cytometer developed specifically to directly quantify …See details»
Evaluation of ViroCyt® Virus Counter for rapid filovirus ... - PubMed
Feb 20, 2015 · The ViroCyt® Virus Counter (VC) 2100 (ViroCyt, Boulder, CO, USA) is a flow-based instrument capable of quantifying virus particles in solution. Using a proprietary …See details»
ViroCyt Develops Rapid Detection System for Enterovirus 71
Oct 20, 2016 · ViroCyt, the innovator in rapid virus quantification, and recently acquired by Sartorius, a leading international pharmaceutical and laboratory equipment provider, has …See details»
Evaluation of ViroCyt® Virus Counter for Rapid Filovirus …
Mar 1, 2015 · The ViroCyt® Virus Counter (VC) 2100 (ViroCyt, Boulder, CO, USA) is a flow-based instrument capable of quantifying virus particles in solution.See details»